从动物研究到临床试验:心脏骤停新型药物治疗的系统评价
该系统评价检索PubMed近20年心脏骤停动物实验,识别415项动物研究、190种药物干预,再检索这些干预的临床试验,发现43项临床试验测试26种干预。13项试验主要终点阳性,30项中性,无研究显示伤害。部分临床试验测试的干预在动物研究中并无阳性结果,且大量动物研究在临床试验发表后才开展。提示动物到临床转化数量有限且时序常倒置。
要点
- 415项动物研究测试190种药物干预,最常见为血管升压药、麻醉药/气体及分子靶向干预。
- 仅26种动物研究干预进入43项临床试验,其中13项阳性、30项中性,无研究显示伤害。
- 部分临床试验测试的干预在动物研究中并无阳性结局,提示转化前证据不充分。
- 大量动物研究在临床试验发表后才进行,转化时序常倒置。
适用人群与场景
- 原文未提及
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 系统评价检索PubMed近20年心脏骤停动物实验,识别415项动物研究、190种药物干预。
- 最常见测试干预分类为血管升压药、麻醉药/气体或分子靶向干预。
- 二次检索识别43项临床试验测试26种动物研究中的干预。
- 13项临床试验主要终点阳性,30项中性,无研究显示伤害。
- 部分临床试验测试的干预在动物研究中无阳性结局;大量动物研究在临床试验发表后开展。
证据类型、等级与局限
- 证据类型:系统评价,检索PubMed近20年动物实验与临床试验,采用标准化数据提取表。
对床旁实践的改变
- 提示当前心脏骤停药物干预从动物到临床的转化数量有限,床旁不宜依据动物研究阳性结果直接改变用药。
- 部分临床试验测试的干预在动物研究中并无阳性结局,提示临床决策需以临床试验结果为准。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There is a lack of new promising therapies to improve the dismal outcomes from cardiac arrest. The objectives of this study were: (1) To identify novel pharmacological therapies investigated in experimental animal studies and (2) to identify pharmacological therapies translated from experimental animal studies to clinical trials.
METHODS: PubMed was searched to first identify relevant experimental cardiac arrest animal models published within the last 20 years. Based on this, a list of interventions was created and a second search was performed to identify clinical trials testing one of these interventions. Data extraction was performed using standardised data extraction forms.
RESULTS: We identified 415 animal studies testing 190 different pharmacological interventions. The most commonly tested interventions were classified as vasopressors, anaesthetics/gases, or interventions aimed at molecular targets. We found 43 clinical trials testing 26 different interventions identified in the animal studies. Of these, 13 trials reported positive findings and 30 trials reported neutral findings with regards to the primary endpoint. No study showed harm of the intervention. Some interventions tested in human clinical trials, had previously been tested in animal studies without a positive effect on outcomes. A large number of animal studies was performed after publication of a clinical trial.
CONCLUSION: Numerous different pharmacological interventions have been tested in experimental animal models. Despite this only a limited number of these interventions have advanced to clinical trials, however several of the clinical trials tested interventions that were first tested in experimental animal models.
参考来源
- Lind PC, Johannsen CM, Vammen L, et al. Translation from animal studies of novel pharmacological therapies to clinical trials in cardiac arrest: A systematic review. Resuscitation. 2020. PMID: 33147523. doi:10.1016/j.resuscitation.2020.10.028
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。